Dabur India Limited (DABUR) — Announcement Announcement

· NSE Neutral
📢 Key Event
US FDA issues Import Alert 66-40 for Dabur's Silvassa plant
💡 Investor Takeaway
The alert poses no financial threat but requires monitoring of corrective actions.
⚠️ Risks
Potential reputational risk from import alert

Dabur India disclosed that the US FDA issued Import Alert 66-40 on June 10, 2026, concerning data integrity issues at its Silvassa plant, but emphasized no financial impact, ongoing operational continuity, and corrective actions to address the findings.

📄 View Original Announcement (PDF)

About Dabur India Limited (DABUR)

Fast Moving Consumer Goods · Personal Products · Listed on NSE

Market Cap: ₹82,955.49 Cr P/E: 46.1

View full DABUR stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.